Trial Profile
A randomized phase 2 study of TS-1 versus CDDP+VNR for adjuvant therapy in patients with non-small cell lung cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 19 May 2021
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Vinorelbine
- Indications Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms LOGIK1702
- 08 Mar 2021 Status changed from discontinued to recruiting.
- 24 Nov 2020 Status changed from recruiting to discontinued.
- 01 Jun 2017 Status changed from not yet recruiting to recruiting.